Bank of Montreal
ABOS icon

Bank of Montreal’s Acumen Pharmaceuticals ABOS Stock Holding History

Bank of Montreal’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-30,885
Closed -$76.6K – 3819
2024
Q2 		$76.6K Sell
30,885
-1,015
-3% -$3.23K ﹤0.01% 3319
2024
Q1 		$132K Buy
+31,900
New +$120K ﹤0.01% 3210
2023
Q1 		– Sell
-58,400
Closed -$326K – 3752
2022
Q4 		$326K Buy
+58,400
New +$392K ﹤0.01% 2857

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Bank of Montreal's ABOS Position: Q3 2024 in Review

Bank of Montreal sold out of Acumen Pharmaceuticals (ABOS) in Q3 2024, closing a stake of 30,885 shares — an estimated $76.6K sold.

Bank of Montreal first reported a position in ABOS in Q4 2022 and held it in 3 quarters. The position peaked at $326K in Q4 2022. 73 funds tracked by Wall St. Rank hold ABOS as of Q3 2024.

  • Bank of Montreal reported no remaining Acumen Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Bank of Montreal sold 30,885 Acumen Pharmaceuticals shares in Q3 2024, an estimated $76.6K.
  • Bank of Montreal first reported a position in Acumen Pharmaceuticals in Q4 2022 and held it in 3 quarters.
  • Bank of Montreal's Acumen Pharmaceuticals position peaked at $326K in Q4 2022.
  • 73 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.